Skip to main content
OpenTrials

Clinical trial condition

Herpes Zoster

Explore clinical trials studying Herpes Zoster. Study availability and eligibility vary by location and protocol.

175 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Herpes Zoster trial results

Active, not recruiting

A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)

NCT07293065

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
  • Henan Center for Diseases Control and Prevention Zhengzhou, Henan, China
  • Hubei Provincial Center for Disease Control and Prevention Wuhan, Hubei, China
  • Yunnan Center For Disease Control and Prevention Kunming, Yunnan, China
View Trial Details
Active, not recruiting

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

NCT05304351

Conditions
Chickenpox, DNA Virus Infections, Herpes Zoster, +5 more
Locations
  • Curevo Investigational Site Tempe, Arizona, United States
  • Curevo Investigational Site Coral Gables, Florida, United States
  • Curevo Investigational Site Tampa, Florida, United States
  • Curevo Investigational Site Oak Brook, Illinois, United States
View all 14 locations
View Trial Details
Active, not recruiting

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

NCT06447779

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
  • Henan Center for Diseases Control and Prevention Zhengzhou, Henan, China
  • Hubei Provincial Center for Disease Control and Prevention Wuhan, Hubei, China
  • Yunnan Center For Disease Control and Prevention Kunming, Yunnan, China
View Trial Details
Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

NCT05371080

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Elkridge, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Hickory, North Carolina, United States
View all 107 locations
View Trial Details

Related conditions